Mononatrii phosphate dihydricus, natrii phosphas dihydricus - Sökresultat

USA - engelska - NLM (National Library of Medicine)

isosorbide mononitrate tablet, extended release

edenbridge pharmaceuticals llc. - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.

USA - engelska - NLM (National Library of Medicine)

isosorbide mononitrate tablet, extended release

american health packaging - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.

USA - engelska - NLM (National Library of Medicine)

ismo- isosorbide mononitrate tablet, film coated

reddy pharmaceuticals, llc - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - tablet, film coated - 20 mg - ismo tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. isosorbide mononitrate is contraindicated in patients who are allergic to it. the recommended regimen of ismo tablets is 20 mg (one tablet) twice daily, with the two doses given 7 hours apart. for most patients, this can be accomplished by taking the first dose on awakening and the second dose 7 hours later. dosage adjustments are not necessary for elderly patients or patients with altered renal or hepatic function. as noted above (clinical pharmacology ), multiple studies of organic nitrates have shown that maintenance of continuous 24-hour plasma levels results in refractory tolerance. the dosing regimen for ismo tablets provides a daily nitr

USA - engelska - NLM (National Library of Medicine)

isosorbide mononitrate tablet, extended release

denton pharma, inc. dba northwind pharmaceuticals - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate extended-release tablets, usp are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral ismn is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.